Difference between revisions of "Henson SM, et al. Curr. Opin. Immunol. (2012) cited as Ref 719 in DOI: 10.1038/s41392-020-0110-5 (Q9982)"
Jump to navigation
Jump to search
(Created claim: Third Author string (P151): Akbar AN, #quickstatements; #temporary_batch_1589999365427) |
(Created claim: Page(s) (P105): 476-481, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1016/j.coi.2012.04.001 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 22554789 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2012
| ||||||||||||||
| Property / Publication Date: 2012 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Curr. Opin. Immunol. | ||||||||||||||
| Property / Published In Name String: Curr. Opin. Immunol. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 24 | ||||||||||||||
| Property / Volume: 24 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Properties of end-stage human T cells defined by CD45RA re-expression (English) | ||||||||||||||
| Property / title: Properties of end-stage human T cells defined by CD45RA re-expression (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 476-481 | ||||||||||||||
| Property / Page(s): 476-481 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:50, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Henson SM, et al. Curr. Opin. Immunol. (2012) cited as Ref 719 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Henson SM
0 references
Riddell NE
0 references
Akbar AN
0 references
2012
0 references
Curr. Opin. Immunol.
0 references
24
0 references
Properties of end-stage human T cells defined by CD45RA re-expression (English)
0 references
476-481
0 references
